DURECT Corporation/$DRRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About DURECT Corporation
Durect Corp is a biopharmaceutical company. It is engaged in the research, development, and manufacturing of pharmaceutical products. The company develops pharmaceutical products based on two categories, which include new chemical entities and proprietary pharmaceutical programs. The company's pipeline products consist of DUR-928, POSIMIR, and others. Geographically, the company operates in the United States, Europe, Japan, and other countries, of which key revenue is derived from Europe.
Ticker
$DRRX
Sector
Primary listing
Employees
13
Headquarters
Website
DRRX Metrics
BasicAdvanced
$59M
-
-$0.12
0.85
-
Price and volume
Market cap
$59M
Beta
0.85
52-week high
$2.64
52-week low
$0.48
Average daily volume
2M
Financial strength
Current ratio
0.985
Quick ratio
0.889
Long term debt to equity
18.719
Total debt to equity
50.244
Profitability
EBITDA (TTM)
-15.182
Gross margin (TTM)
251.12%
Net profit margin (TTM)
-209.90%
Operating margin (TTM)
-926.67%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
-45.34%
Return on equity (TTM)
-307.39%
Valuation
Price to revenue (TTM)
35.782
Price to book
17.02
Price to tangible book (TTM)
78.22
Price to free cash flow (TTM)
-4.245
Free cash flow yield (TTM)
-23.56%
Free cash flow per share (TTM)
-0.45
Growth
Revenue change (TTM)
47.68%
Earnings per share change (TTM)
-81.88%
3-year revenue growth (CAGR)
-50.25%
10-year revenue growth (CAGR)
-21.11%
3-year earnings per share growth (CAGR)
-58.83%
10-year earnings per share growth (CAGR)
-24.81%
DRRX News
AllArticlesVideos
Bausch Health Adds Late-Stage Ready Alcohol Liver Disease Drug Candidate In $63 Million DURECT Buyout
Benzinga·3 weeks ago
DRRX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of DURECT Corporation Is Fair to Shareholders
Business Wire·3 weeks ago
Shareholder Alert: The Ademi Firm Investigates Whether DURECT Corporation Is Obtaining a Fair Price for Its Public Shareholders
Business Wire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for DURECT Corporation stock?
DURECT Corporation (DRRX) has a market cap of $59M as of August 18, 2025.
What is the P/E ratio for DURECT Corporation stock?
The price to earnings (P/E) ratio for DURECT Corporation (DRRX) stock is 0 as of August 18, 2025.
Does DURECT Corporation stock pay dividends?
No, DURECT Corporation (DRRX) stock does not pay dividends to its shareholders as of August 18, 2025.
When is the next DURECT Corporation dividend payment date?
DURECT Corporation (DRRX) stock does not pay dividends to its shareholders.
What is the beta indicator for DURECT Corporation?
DURECT Corporation (DRRX) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.